Developing new solutions to support performance and address inflammation can mean going beyond ‘popular’ ingredients into unique offerings. While there is a great amount of consumer and market interest in cannabidiol (CBD), there remain market and regulatory constraints, as well as questions on its efficacy for addressing certain conditions. However, there are other ingredient options that may be better suited for addressing issues such as recovery, pain, sleep, and immune health. Palmitoylethanolamide (PEA) is one such ingredient that has scientifically supported efficacy in these areas, and may serve as an alternative to CBD. Gencor Pacific offers Levagen®+, a bioavailable PEA powered by LipiSperse® technology. In this podcast, sponsored by Gencor Pacific, you’ll hear more about: The legal, safety and efficacy challenges of CBDHow the endocannabinoid system functions and its benefitsFunctional impacts of PEA and its similarity to CBDBenefits of Levagen®+ over standard PEAGuest: Mariko Hill, Global Innovation Manager, Gencor PacificIf you do like the show, make sure to subscribe and follow the Vitafoods Insights podcast. Feel free also to recommend the show to a friend that you think would enjoy it.       For more content from Vitafoods Insights, make sure to check our website:  https://www.vitafoodsinsights.com    To learn more about sponsorships opportunities, click here and make sure to check our media kit.

Ver todos los episodios